Transcriptional Activation by the Product of Open Reading Frame 50 of Kaposi’s Sarcoma-Associated Herpesvirus Is Required for Lytic Viral Reactivation in B Cells
暂无分享,去创建一个
[1] Lijun Wu,et al. A Complex Translational Program Generates Multiple Novel Proteins from the Latently Expressed Kaposin (K12) Locus of Kaposi’s Sarcoma-Associated Herpesvirus , 1999, Journal of Virology.
[2] A. Haase,et al. Expression of the Open Reading Frame 74 (G-Protein-Coupled Receptor) Gene of Kaposi’s Sarcoma (KS)-Associated Herpesvirus: Implications for KS Pathogenesis , 1999, Journal of Virology.
[3] F. Zhu,et al. Identification of the Immediate-Early Transcripts of Kaposi’s Sarcoma-Associated Herpesvirus , 1999, Journal of Virology.
[4] A. Palestine,et al. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. , 1999, The New England journal of medicine.
[5] R. Sun,et al. Kinetics of Kaposi’s Sarcoma-Associated Herpesvirus Gene Expression , 1999, Journal of Virology.
[6] H. Kung,et al. Kaposi’s Sarcoma-Associated Herpesvirus Encodes a bZIP Protein with Homology to BZLF1 of Epstein-Barr Virus , 1999, Journal of Virology.
[7] H. Gruffat,et al. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) encodes a homologue of the Epstein-Barr virus bZip protein EB1. , 1999, The Journal of general virology.
[8] R. Desrosiers,et al. Identification and Characterization of Kaposi’s Sarcoma-Associated Herpesvirus K8.1 Virion Glycoprotein , 1999, Journal of Virology.
[9] D. Ganem,et al. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. , 1998, Virology.
[10] W. Kolch,et al. Activation of the Epstein-Barr Virus Transcription Factor BZLF1 by 12-O-Tetradecanoylphorbol-13-Acetate-Induced Phosphorylation , 1998, Journal of Virology.
[11] T. Ragoczy,et al. The Epstein-Barr Virus Rta Protein Activates Lytic Cycle Genes and Can Disrupt Latency in B Lymphocytes , 1998, Journal of Virology.
[12] R. Sun,et al. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] T. Schulz,et al. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). , 1998, The Journal of general virology.
[14] R. Ricciardi,et al. Cloning and Functional Analysis of Kaposi’s Sarcoma-Associated Herpesvirus DNA Polymerase and Its Processivity Factor , 1998, Journal of Virology.
[15] Jeffrey N. Martin,et al. Sexual transmission and the natural history of human herpesvirus 8 infection. , 1998, The New England journal of medicine.
[16] F. Neipel,et al. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. , 1998, Journal of virology.
[17] P. Moore,et al. Transcription Mapping of the Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Genome in a Body Cavity-Based Lymphoma Cell Line (BC-1) , 1998, Journal of Virology.
[18] B. Chandran,et al. Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF 59 protein and the encoding cDNA by monoclonal antibody. , 1998, Virology.
[19] E. Cesarman,et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.
[20] C. Boshoff,et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. , 1997, Science.
[21] B. Haar,et al. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8 , 1997, Journal of virology.
[22] F. Neipel,et al. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? , 1997, Journal of virology.
[23] E. Cesarman,et al. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation , 1997, Nature.
[24] A. Haase,et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells , 1997, Journal of virology.
[25] J. Russo,et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[26] S. Kenney,et al. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] W. Zhong,et al. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[28] M. McGrath,et al. Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture , 1996, Nature Medicine.
[29] L. Corbo,et al. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome. , 1996, The Journal of general virology.
[30] J. Countryman,et al. Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras , 1996, Journal of virology.
[31] D R Hoover,et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma , 1996, AIDS.
[32] C. Boshoff,et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells , 1995, Nature Medicine.
[33] C. Boshoff,et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma , 1995, The Lancet.
[34] F. Sigaux,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.
[35] E. Cesarman,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.
[36] J. Ambroziak,et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. , 1995, Science.
[37] J. Levy,et al. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals , 1994, AIDS.
[38] H. Gruffat,et al. Characterization of the DNA-binding site repertoire for the Epstein-Barr virus transcription factor R. , 1994, Nucleic acids research.
[39] F. Furnari,et al. RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism , 1994, Journal of virology.
[40] A. Berk,et al. Functional interaction of adenovirus E1A with holo-TFIID. , 1993, Genes & development.
[41] D. Gutsch,et al. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1. , 1993, Nucleic acids research.
[42] E. Fearon,et al. Karyoplasmic interaction selection strategy: a general strategy to detect protein-protein interactions in mammalian cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[43] M. Stürzl,et al. Cellular and molecular features of HIV-associated Kaposi's sarcoma. , 1992, AIDS.
[44] J M Hardwick,et al. The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16 , 1992, Journal of virology.
[45] R. Buckland,et al. Characterization of an R-binding site mediating the R-induced activation of the Epstein-Barr virus BMLF1 promoter , 1992, Journal of virology.
[46] J. Giot,et al. Domains of the Epstein-Barr virus (EBV) transcription factor R required for dimerization, DNA binding and activation. , 1991, Nucleic acids research.
[47] P. Farrell,et al. Pathways of activation of the Epstein-Barr virus productive cycle , 1991, Journal of virology.
[48] W. D. Cress,et al. Critical structural elements of the VP16 transcriptional activation domain. , 1991, Science.
[49] S. Kenney,et al. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner , 1990, Journal of virology.
[50] G. Miller. The switch between latency and replication of Epstein-Barr virus. , 1990, The Journal of infectious diseases.
[51] E. Flemington,et al. Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1 , 1990, Journal of virology.
[52] J. Hardwick,et al. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators , 1990, Journal of virology.
[53] K. Takada,et al. Identification of an enhancer-type sequence that is responsive to Z and R trans-activators of Epstein-Barr virus. , 1989, Virology.
[54] S. Kenney,et al. The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators , 1989, Journal of virology.
[55] I. Verma,et al. Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum , 1987, Molecular and cellular biology.
[56] P. Chavrier,et al. Both Epstein‐Barr virus (EBV)‐encoded trans‐acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. , 1986, The EMBO journal.
[57] J. Countryman,et al. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.